Literature DB >> 8959424

Measuring effectiveness of eye movement desensitization and reprocessing (EMDR) in non-clinical anxiety: a multi-subject, yoked-control design.

T M Dunn1, M Schwartz, R W Hatfield, M Wiegele.   

Abstract

Twenty-eight subjects from a university's subject pool were paired on sex, age, severity, and type of stressful or traumatic incident. One subject in each pair was selected to receive EMDR; the experimental partner spent the same amount of time receiving a visual (non-movement) placebo. Subjective units of discomfort (SUD) scores and physiological measurements were taken prior to and following treatment. Analysis of physiological measurements and self-reported levels of stress were performed within and between each group. While the EMDR group showed significant reductions of stress, EMDR was no better than a placebo. This suggests EMDR's specific intervention involving eye movement may not be a necessary component of the treatment protocol.

Entities:  

Mesh:

Year:  1996        PMID: 8959424     DOI: 10.1016/s0005-7916(96)00034-1

Source DB:  PubMed          Journal:  J Behav Ther Exp Psychiatry        ISSN: 0005-7916


  3 in total

1.  Improvement of mood and sleep alterations in posttraumatic stress disorder patients by eye movement desensitization and reprocessing.

Authors:  Mara R Raboni; Fabiana F D Alonso; Sergio Tufik; Deborah Suchecki
Journal:  Front Behav Neurosci       Date:  2014-06-10       Impact factor: 3.558

2.  Efficacy of eye-movement desensitization and reprocessing for patients with posttraumatic-stress disorder: a meta-analysis of randomized controlled trials.

Authors:  Ying-Ren Chen; Kuo-Wei Hung; Jui-Chen Tsai; Hsin Chu; Min-Huey Chung; Su-Ru Chen; Yuan-Mei Liao; Keng-Liang Ou; Yue-Cune Chang; Kuei-Ru Chou
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

3.  Reducing the Emotionality of Auditory Hallucination Memories in Patients Suffering From Auditory Hallucinations.

Authors:  Suzy Johanna Martina Adriana Matthijssen; Ivo Heitland; Liselotte C M Verhoeven; Marcel A van den Hout
Journal:  Front Psychiatry       Date:  2019-09-18       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.